Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

What is the Optimal antiplatElet & Anticoagulant Therapy in Patients With Oral Anticoagulation and Coronary StenTing

NCT00769938 is registered in ClinicalTrials.gov with R&D Cardiologie as lead sponsor.

NCT NCT00769938
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00769938 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
What is the Optimal antiplatElet & Anticoagulant Therapy in Patients With Oral Anticoagulation and Coronary StenTing
Lead sponsor
R&D Cardiologie
Phase
Phase 4
Overall status
Completed
Start date
December 31, 2008
Completion date
August 31, 2012
Enrollment
573 (actual)
Sites
15

Conditions

As the registry lists them; a condition with its own page is linked.

anticoagulants, atrial fibrillation, platelet aggregation inhibitors, stents